Physician profile
Umar Nasir
NPI 1972845709
$6,088.72
in general payments reported to CMS, 2019-2025
11 companies · $796 in 2025
The $796 reported for 2025 was more than what a typical Sleep Medicine (Family Medicine) provider received nationally (typical 2025 total: $557).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.45 · 2022: $3,444 · 2023: $1,026 · 2024: $783 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,463 · Education: $90.00 · Travel and Lodging: $52.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,462.54 |
| Education | $90.00 |
| Travel and Lodging | $52.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $5,056.92 | 2022-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $330.88 | 2022-2023 | Xywav |
| Fisher & Paykel Healthcare INC | $281.52 | 2022-2025 | Fisher & Paykel Healthcare |
| Novo Nordisk INC | $139.29 | 2025 | Wegovy |
| Harmony Biosciences LLC | $86.42 | 2022-2024 | |
| Avadel Cns Pharmaceuticals, LLC | $51.70 | 2025 | Lumryz |
| Axsome Therapeutics, INC. | $50.96 | 2025 | Sunosi |
| Philips North America LLC | $39.45 | 2019 | |
| 3b Medical, INC. | $18.67 | 2023 | Luna |
| Zoll Respicardia, INC. | $17.35 | 2025 | Remede System |
| Resmed Corp | $15.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umar Nasir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.